The progenitor of SARS-CoV-2 remains unknown, according to a preliminary report released on 9 June 2022 by the WHO panel. Jesse Bloom pondered about the SARS-CoV-2 emergence long before December 2019, putting in check the joint WHO-China report. In addition, a rare conflict of interest occurred: ‘Mr. Inattention’ was a member of the team that the WHO sent to China in 2021 to investigate the COVID-19 origin. The presence of ‘Mr. Inattention’ provides evidence that WHO overlooked a troubling possibility: apparently, there were those who had at least planned to develop full-length infectious clones of bat SARS-related coronaviruses, with insertion of a fragment (proteolytic cleavage site) of this virus into bat coronaviruses, such a cleavage site being able to interact with furin, an enzyme expressed in human cells. Some moral threshold may have been damaged, threatening civilizational security and public health, given the hypothesis of an unnatural origin of SARS-CoV-2. In other words, there is a possibility of a lab-associated origin of this novel pathogen. This makes it illegal to patent vaccines against COVID-19 in Brazil and all other 192 member states of the World Intellectual Property Organization (WIPO), at least as long as such suspicion exists.